[1]
|
Rawla, P., Sunkara, T. and Gaduputi, V. (2019) Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World Journal of Oncology, 10, 10-27. https://doi.org/10.14740/wjon1166
|
[2]
|
Matsubayashi, H., Ishi-watari, H., Sasaki, K., Uesaka, K. and Ono, H. (2020) Detecting Early Pancreatic Cancer: Current Problems and Future Prospects. Gut and Liver, 14, 30-36. https://doi.org/10.5009/gnl18491
|
[3]
|
Xia, C., Dong, X., Li, H., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and Determinants. Chinese Medical Journal, 135, 584-590. https://doi.org/10.1097/CM9.0000000000002108
|
[4]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30.
https://doi.org/10.3322/caac.21590
|
[5]
|
Zeng, H., Chen, W., Zheng, R., et al. (2018) Changing Cancer Survival in China during 2003-15: A Pooled Analysis of 17 Population-Based Cancer Registries. The Lancet Global Health, 6, e555-e567.
https://doi.org/10.1016/S2214-109X(18)30127-X
|
[6]
|
Singhi, A.D., Koay, E.J., Chari, S.T. and Maitra, A. (2019) Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology, 156, 2024-2040. https://doi.org/10.1053/j.gastro.2019.01.259
|
[7]
|
Ishikawa, O., Ohigashi, H., Imaoka, S., et al. (1999) Minute Car-cinoma of the Pancreas Measuring 1 cm or Less in Diameter—Collective Review of Japanese Case Reports. Hepatogas-troenterology, 46, 8-15.
|
[8]
|
Tsuchiya, R., Noda, T., Harada, N., et al. (1986) Collective Review of Small Carcinomas of the Pancreas. Annals of Surgery, 203, 77-81. https://doi.org/10.1097/00000658-198601000-00013
|
[9]
|
Owens, D.K., Davidson, K.W., Krist, A.H., et al. (2019) Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA, 322, 438-444.
https://doi.org/10.1001/jama.2019.10232
|
[10]
|
Goggins, M., Overbeek, K.A., Brand, R., et al. (2020) Management of Patients with Increased Risk for Familial Pancreatic Cancer: Updated Recommendations From the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut, 69, 7-17. https://doi.org/10.1136/gutjnl-2019-319352
|
[11]
|
沈珊珊, 李洪祯, 余媛媛. 中国胰腺癌高危人群早期筛查和监测共识意见(2021, 南京) [J]. 临床肝胆病杂志. 2022, 38(5): 1016-1022.
|
[12]
|
Giovannucci, E., Harlan, D.M., Archer, M.C., et al. (2010) Diabetes and Cancer: A Consensus Report. Diabetes Care, 33, 1674-1685. https://doi.org/10.2337/dc10-0666
|
[13]
|
Maisonneuve, P. and Lowenfels, A.B. (2015) Risk Factors for Pancreatic Cancer: A Summary Review of Meta-Analytical Studies. International Journal of Epidemiology, 44, 186-198. https://doi.org/10.1093/ije/dyu240
|
[14]
|
Sacerdote, C. and Ricceri, F. (2018) Epide-miological Dimensions of the Association between Type 2 Diabetes and Cancer: A Review of Observational Studies. Diabetes Research and Clinical Practice, 143, 369-377.
https://doi.org/10.1016/j.diabres.2018.03.002
|
[15]
|
Pannala, R., Leirness, J.B., Bamlet, W.R., et al. (2008) Preva-lence and Clinical Profile of Pancreatic Cancer-Associated Diabetes Mellitus. Gastroenterology, 134, 981-987. https://doi.org/10.1053/j.gastro.2008.01.039
|
[16]
|
Ballotari, P., Vicentini, M., Manicardi, V., et al. (2017) Diabetes and Risk of Cancer Incidence: Results from a Population-Based Cohort Study in Northern Italy. BMC Cancer, 17, Article No. 703.
https://doi.org/10.1186/s12885-017-3696-4
|
[17]
|
Berger, S.M., Gislason, G., Moore, L.L., et al. (2016) Associa-tions between Metabolic Disorders and Risk of Cancer in Danish Men and Women—A Nationwide Cohort Study. BMC Cancer, 16, Article No. 133.
https://doi.org/10.1186/s12885-016-2122-7
|
[18]
|
Dankner, R., Boffetta, P., Balicer, R.D., et al. (2016) Time-Dependent Risk of Cancer after a Diabetes Diagnosis in a Cohort of 2.3 Million Adults. American Journal of Epi-demiology, 183, 1098-1106.
https://doi.org/10.1093/aje/kwv290
|
[19]
|
Kang, Y.M., Kim, Y.-J., Park, J.-Y., Lee, W.J. and Jung, C.H. (2016) Mortality and Causes of Death in a National Sample of Type 2 Diabetic Patients in Korea from 2002 to 2013. Cardio-vascular Diabetology, 15, Article No. 131.
https://doi.org/10.1186/s12933-016-0451-0
|
[20]
|
Lin, C.-C., Chiang, J.-H., Li, C.-I., et al. (2014) Cancer Risks among Patients with Type 2 Diabetes: A 10-Year Follow-Up Study of a Nationwide Population-Based Cohort in Taiwan. BMC Cancer, 14, Article No. 381.
https://doi.org/10.1186/1471-2407-14-381
|
[21]
|
Everhart, J. and Wright, D. (1995) Diabetes Mellitus as a Risk Factor for Pancreatic Cancer: A Meta-Analysis. JAMA, 273, 1605-1609. https://doi.org/10.1001/jama.1995.03520440059037
|
[22]
|
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F. and Woodward, M. (2005) Type-II Diabetes and Pancreatic Cancer: A Meta-Analysis of 36 Studies. British Journal of Cancer, 92, 2076-2083.
https://doi.org/10.1038/sj.bjc.6602619
|
[23]
|
Aggarwal, G., Rabe, K.G., Petersen, G.M. and Chari, S.T. (2012) New-Onset Diabetes in Pancreatic Cancer: A Study in the Primary Care Setting. Pancreatology, 12, 156-161. https://doi.org/10.1016/j.pan.2012.02.003
|
[24]
|
Mizuno, S., Nakai, Y., Isayama, H., et al. (2013) Diabetes Is a Useful Diagnostic Clue to Improve the Prognosis of Pancreatic Cancer. Pancreatology, 13, 285-289. https://doi.org/10.1016/j.pan.2013.03.013
|
[25]
|
Setiawan, V.W., Stram, D.O., Porcel, J., et al. (2019) Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort. Journal of the National Cancer Institute, 111, 27-33.
https://doi.org/10.1093/jnci/djy090
|
[26]
|
Pereira, S.P., Oldfield, L., Ney, A., et al. (2020) Early Detection of Pan-creatic Cancer. The Lancet Gastroenterology & Hepatology, 5, 698-710. https://doi.org/10.1016/S2468-1253(19)30416-9
|
[27]
|
Chari, S.T., Leibson, C.L., Rabe, K.G., et al. (2008) Pancre-atic Cancer-Associated Diabetes Mellitus: Prevalence and Temporal Association with Diagnosis of Cancer. Gastroenter-ology, 134, 95-101.
https://doi.org/10.1053/j.gastro.2007.10.040
|
[28]
|
Pannala, R., Basu, A., Petersen, G.M. and Chari, S.T. (2009) New-Onset Diabetes: A Potential Clue to the Early Diagnosis of Pancreatic Cancer. The Lancet Oncology, 10, 88-95. https://doi.org/10.1016/S1470-2045(08)70337-1
|
[29]
|
Illés, D., Terzin, V., Holzinger, G., et al. (2016) New-Onset Type 2 Diabetes Mellitus—A High-Risk Group Suitable for the Screening of Pancreatic Cancer? Pancreatology, 16, 266-271. https://doi.org/10.1016/j.pan.2015.12.005
|
[30]
|
Chari, S.T., Klee, G.G., Miller, L.J., Raimondo, M. and DiMagno, E.P. (2001) Islet Amyloid Polypeptide Is Not a Satisfactory Marker for Detecting Pancreatic Cancer. Gastro-enterology, 121, 640-645.
https://doi.org/10.1053/gast.2001.27210
|
[31]
|
Batabyal, P., Vander Hoorn, S., Christophi, C., et al. (2014) Associa-tion of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies. Annals of Surgical Oncology, 21, 2453-2462.
https://doi.org/10.1245/s10434-014-3625-6
|
[32]
|
Yuan, C., Babic, A., Khalaf, N., et al. (2020) Diabetes, Weight Change, and Pancreatic Cancer Risk. JAMA Oncology, 6, e202948. https://doi.org/10.1001/jamaoncol.2020.2948
|
[33]
|
Ben, Q., Xu, M., Ning, X., et al. (2011) Diabetes Mellitus and Risk of Pancreatic Cancer: A Meta-Analysis of Cohort Studies. European Journal of Cancer, 47, 1928-1937. https://doi.org/10.1016/j.ejca.2011.03.003
|
[34]
|
Guo, Q., Kang, M., Zhang, B., et al. (2010) Elevated Levels of CA 19-9 and CEA in Pancreatic Cancer-Associated Diabetes. Journal of Cancer Research and Clinical Oncology, 136, 1627-1631.
https://doi.org/10.1007/s00432-010-0820-0
|
[35]
|
Sah, R., Nagpal, S., Mukhopadhyay, D., et al. (2013) New In-sights into Pancreatic Cancer-Induced Paraneoplastic Diabetes. Nature Reviews Gastroenterology & Hepatology, 10, 423-433. https://doi.org/10.1038/nrgastro.2013.49
|
[36]
|
Basso, D., Brigato, L., Veronesi, A., et al. (1995) The Pancreatic Cancer Cell Line MIA PaCa2 Produces One or More Factors Able to Induce Hyperglycemia in SCID Mice. Anticancer Research, 15, 2585-2588.
|
[37]
|
Aggarwal, G., Ramachandran, V., Javeed, N., et al. (2012) Adrenomedullin Is up-Regulated in Patients with Pancreatic Cancer and Causes Insulin Resistance in β Cells and Mice. Gastroenterology, 143, 1510-1517.
https://doi.org/10.1053/j.gastro.2012.08.044
|
[38]
|
Basso, D., Valerio, A., Brigato, L., et al. (1997) An Unidentified Pancreatic Cancer Cell Product Alters Some Intracellular Pathways of Glucose Metabolism in Isolated Rat Hepatocytes. Pancreas, 15, 132-138.
https://doi.org/10.1097/00006676-199708000-00004
|
[39]
|
Valerio, A., Basso, D., Brigato, L., et al. (1999) Glucose Metabolic Alterations in Isolated and Perfused Rat Hepatocytes Induced by Pancreatic Cancer Conditioned Medium: A Low Molecular Weight Factor Possibly Involved. Biochemical and Biophysical Research Communications, 257, 622-628. https://doi.org/10.1006/bbrc.1999.0521
|
[40]
|
Javeed, N., Sagar, G., Dutta, S.K., et al. (2015) Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-Cell Dysfunction. Clinical Cancer Research, 21, 1722-1733. https://doi.org/10.1158/1078-0432.CCR-14-2022
|
[41]
|
Chari, S.T., Leibson, C.L., Rabe, K.G., et al. (2005) Proba-bility of Pancreatic Cancer Following Diabetes: A Population-Based Study. Gastroenterology, 129, 504-511. https://doi.org/10.1016/j.gastro.2005.05.007
|
[42]
|
Pannala, R., Leibson, C.L., Rabe, K.G., et al. (2009) Temporal Association of Changes in Fasting Blood Glucose and Body Mass Index with Diagnosis of Pancreatic Cancer. The American Journal of Gastroenterology, 104, 2318-2325.
https://doi.org/10.1038/ajg.2009.253
|
[43]
|
Permert, J., Ihse, I., Jorfeldt, L., et al. (1993) Pancreatic Cancer Is Asso-ciated with Impaired Glucose Metabolism. The European Journal of Surgery, 159, 101-107.
|
[44]
|
Fogar, P., Pasquali, C., Basso, D., et al. (1994) Diabetes Mellitus in Pancreatic Cancer Follow-up. Anticancer Research, 14, 2827-2830.
|
[45]
|
Sharma, A., Smyrk, T.C., Levy, M.J., Topazian, M.A. and Chari, S.T. (2018) Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer before Diagnosis. Gastroenterology, 155, 490-500.
https://doi.org/10.1053/j.gastro.2018.04.025
|
[46]
|
Pelaez-Luna, M., Takahashi, N., Fletcher, J.G. and Chari, S.T. (2007) Resectability of Presymptomatic Pancreatic Cancer and Its Relationship to Onset of Diabetes: A Retrospective Re-view of CT Scans and Fasting Glucose Values Prior to Diagnosis. The American Journal of Gastroenterology, 102, 2157-2163.
https://doi.org/10.1111/j.1572-0241.2007.01480.x
|
[47]
|
Zhang, Z., Qin, W. and Sun, Y. (2018) Contribution of Biomarkers for Pancreatic Cancer-Associated New-Onset Diabetes to Pancreatic Cancer Screening. Pathology-Research and Practice, 214, 1923-1928.
https://doi.org/10.1016/j.prp.2018.10.003
|
[48]
|
Kang, M., Qin, W., Buya, M., et al. (2016) VNN1, A Potential Bi-omarker for Pancreatic Cancer-Associated New-Onset Diabetes, Aggravates Paraneoplastic Islet Dysfunction by In-creasing Oxidative Stress. Cancer Letters, 373, 241-250. https://doi.org/10.1016/j.canlet.2015.12.031
|
[49]
|
Kolb, A., Rieder, S., Born, D., et al. (2009) Glucagon/insulin Ratio as a Potential Biomarker for Pancreatic Cancer in Patients with New-Onset Diabetes Mellitus. Cancer Biology & Therapy, 8, 1527-1533.
https://doi.org/10.4161/cbt.8.16.9006
|
[50]
|
Hart, P.A., Baichoo, E., Bi, Y., et al. (2015) Pancreatic Polypeptide Re-sponse to a Mixed Meal Is Blunted in Pancreatic Head Cancer Associated with Diabetes Mellitus. Pancreatology, 15, 162-166.
https://doi.org/10.1016/j.pan.2015.02.006
|
[51]
|
La Torre, G., Sferrazza, A., Gualano, M.R., et al. (2014) Investi-gating the Synergistic Interaction of Diabetes, Tobacco Smoking, Alcohol Consumption, and Hypercholesterolemia on the Risk of Pancreatic Cancer: A Case-Control Study in Italy. BioMed Research International, 2014, Article ID: 481019. https://doi.org/10.1155/2014/481019
|
[52]
|
Bo, X., Shi, J., Liu, R., et al. (2019) Using the Risk Factors of Pancreatic Cancer and Their Interactions in Cancer Screening: A Case-Control Study in Shanghai, China. Annals of Global Health, 85, 103.
https://doi.org/10.5334/aogh.2463
|
[53]
|
Hart, P.A., Kamada, P., Rabe, K.G., et al. (2011) Weight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes Mellitus. Pancreas, 40, 768-772. https://doi.org/10.1097/MPA.0b013e318220816a
|
[54]
|
Huang, B.Z., Pandol, S.J., Jeon, C.Y., et al. (2020) New-Onset Diabetes, Longitudinal Trends in Metabolic Markers, and Risk of Pancreatic Cancer in a Heterogeneous Population. Clinical Gastroenterology and Hepatology, 18, 1812-1821. https://doi.org/10.1016/j.cgh.2019.11.043
|
[55]
|
Boursi, B., Finkelman, B., Giantonio, B.J., et al. (2017) A Clinical Prediction Model to Assess Risk for Pancreatic Cancer among Patients with New-Onset Diabetes. Gastroenterology, 152, 840-850.
https://doi.org/10.1053/j.gastro.2016.11.046
|
[56]
|
Sharma, A., Kandlakunta, H., Nagpal, S.J.S., et al. (2018) Model to Determine Risk of Pancreatic Cancer in Patients with New-Onset Diabetes. Gastroenterology, 155, 730-739. https://doi.org/10.1053/j.gastro.2018.05.023
|
[57]
|
American Diabetes Association (2019) Classification and Diag-nosis of Diabetes: Standards of Medical Care in Diabetes—2019. Diabetes Care, 42, S13-S28. https://doi.org/10.2337/dc19-S002
|
[58]
|
Yusoff, I.F. and Sahai, A.V. (2004) A Prospective, Quantitative Assess-ment of the Effect of Ethanol and Other Variables on the Endosonographic Appearance of the Pancreas. Clinical Gastro-enterology and Hepatology, 2, 405-409.
https://doi.org/10.1016/S1542-3565(04)00126-0
|
[59]
|
Canto, M.I., Goggins, M., Yeo, C.J., et al. (2004) Screening for Pancreatic Neoplasia in High-Risk Individuals: An EUS-Based Approach. Clinical Gastroenterology and Hepatology, 2, 606-621.
https://doi.org/10.1016/S1542-3565(04)00244-7
|
[60]
|
秦文杰. VNN1对胰腺癌癌旁胰岛的影响及USPIO-VNN1对胰腺癌细胞示踪作用的研究[D]: [博士学位论文]. 杭州: 浙江大学, 2016.
|
[61]
|
Huang, H., Dong, X., Kang, M.X., et al. (2010) Novel Blood Biomarkers of Pancreatic Cancer-Associated Diabetes Mellitus Identi-fied by Peripheral Blood-Based Gene Expression Profiles. The American Journal of Gastroenterology, 105, 1661-1669. https://doi.org/10.1038/ajg.2010.32
|